Autism Spectrum Disorder Trial, Recruiting NCT06950437 Sponsor: Beijing Changping Tianhe Research Institute of Brain Science Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06950437
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child has been formally diagnosed with Autism Spectrum Disorder (ASD) by a professional, based on recognised diagnostic guidelines (DSM-5).
  • The child is between 3 and 6.5 years old, of any gender.
  • The child's results from a standardised autism assessment tool (called the ADOS-2) meet the recognised threshold for an ASD diagnosis.
  • The child scores at or above a set level on a behaviour checklist used to assess autism-related traits (called the SCQ), with the required score depending on the child's age.
  • The child may have a language difficulty, but this alone does not fully explain their ASD symptoms; there are no physical problems with the child's speech organs; and the child's language development, as measured by specific assessment tools, meets certain minimum levels (confirm with trial site).
  • Mandarin is the language the child uses day-to-day for communication.
  • The child may also have an intellectual or general developmental delay, as long as this does not fully explain their ASD symptoms.
  • The child's guardians are willing to participate, can cooperate with the treatment process, and are able to sign a consent form.

Who may not be able to join:

  • The child has a known genetic cause identified for their condition, or has a current or past diagnosis of a serious additional condition such as ADHD or Tourette's syndrome.
  • The child has engaged in serious self-harm at any point in the past year.
  • The child has significant sensory or movement difficulties that would prevent them from cooperating with the trial.
  • The child has a history of epileptic seizures.
  • The child has a serious physical illness, particularly one affecting the brain.
  • The child has metal implants or other factors that would make MRI scans or a brain stimulation technique called TMS unsafe.
  • The child has breathing or circulation problems that would make sedation risky.
  • The child's guardians are unable to read or write, and therefore cannot manage the consent forms or questionnaires involved in the trial.
  • The child has received any form of brain stimulation treatment in the past 3 months.
  • The child is currently participating in another clinical trial.
  • The trial researcher considers the child unsuitable for reasons not listed above.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13691009590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Changping Tianhe Research Institute of Brain Science
Registry
ClinicalTrials.gov
Start date
25 April 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

CLAS-TP score change after treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov